Morning Overview on MSN
AI blood test spots early pancreatic cancer with up to 94% accuracy
Researchers at Academia Sinica and National Taiwan University Hospital have developed an AI-powered blood test that detects early-stage pancreatic cancer with near-perfect accuracy in validation ...
A new blood test that uses artificial intelligence (AI) may offer a faster, more accurate way to determine whether pancreatic cancer treatment is working. Known as ARTEMIS-DELFI, the test detects DNA ...
Scientists from Oregon Health & Science University have developed a blood test called PAC-MANN that is said to be less invasive, cheaper and more robust than traditional screening methods for ...
Healthcare professionals consider a healthy pancreatic elastase level above 200 micrograms per gram (mcg/g). Pancreatic elastase is the digestive enzyme that the pancreas produces to help digest food.
A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. The test combines four ...
Stock image of blood samples in a lab setting. Researchers have developed an inexpensive blood test that they say can detect pancreatic cancer — even in its early stages. Using a small blood sample, ...
Speedier Test: OHSU cancer researchers Jared Fischer, Ph.D., left, and Jose Luis Montoya Mira, Ph.D. ((OHSU/Christine Torres Hicks)) If there’s one kind of cancer that no one wants, it’s cancer of the ...
Although there currently is no single recommended blood test to find early pancreatic cancers, “there is a large scientific community working to try to change this and to identify a screening test ...
Proprietary multianalyte and multiomic assay with optimized machine learning capabilities achieve significantly higher 82% sensitivity and 97% specificity in high-risk populations SAN DIEGO, February ...
SAN DIEGO--(BUSINESS WIRE)--ClearNote Health, an early cancer detection company focused on enabling people at risk for high-mortality cancers to live longer, healthier lives, today announced the ...
The new test works by detecting two sugars - CA199.STRA and CA19-9 - that are produced by pancreatic cancer cells and escape into the bloodstream. CA19-9 is the current gold-standard biomarker for ...
A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results